Regular ArticlesAn Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
Cited by (0)
Supported by grants from the NIH/NCI (R01-CA-80250; R01-CA-098779; R01-CA-120876, the American Association for Cancer Research, and the Department of Defense-Breast Cancer Research Program (Synergistic Idea Award) (to M.P.L.). A.K.W was supported by a Young Investigator Award from Breast Cancer Alliance, Inc. and a Susan G. Komen Career Catalyst Grant. F.S. was supported by grants from the Elsa U. Pardee Foundation, the W.W. Smith Charitable Trust, and a Research Scholar Grant from the American Cancer Society. C.G.K. was supported by NIH/NCI grants (R01-CA-090876; R01-CA107469) and a grant from the Avon Foundation. This project is funded, in part, under a grant with the Pennsylvania Department of Health (to M.P.L.). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. R.G.P. was supported by grants from the NIH/NCI (R01-CA-70896, R01-CA-75503, R01-CA-86072, and R01-CA-107382) and the Dr. Ralph and Marian C. Falk Medical Research Trust. The Kimmel Cancer Center was supported by the NIH/NCI Cancer Center Core grant P30-CA-56036 (to R.G.P.).
A.K.W. and A.D. contributed equally and should be considered co-first authors.
Supplemental material for this article can be found on http://ajp.amjpathol.org.
A guest editor acted as editor-in-chief for this manuscript. No person at Thomas Jefferson University or Albert Einstein College of Medicine was involved in the peer review process or final disposition for this article.